Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 09:43AM ET
89.95
Dollar change
-0.36
Percentage change
-0.40
%
IndexNDX, S&P 500 P/E29.74 EPS (ttm)3.02 Insider Own7.48% Shs Outstand455.34M Perf Week-1.37%
Market Cap40.96B Forward P/E18.62 EPS next Y4.83 Insider Trans0.00% Shs Float421.28M Perf Month-3.30%
Income1.39B PEG2.46 EPS next Q0.90 Inst Own70.14% Short Float2.92% Perf Quarter15.81%
Sales19.55B P/S2.09 EPS this Y9.18% Inst Trans- Short Ratio3.43 Perf Half Y31.74%
Book/sh15.67 P/B5.74 EPS next Y12.61% ROA5.24% Short Interest12.29M Perf Year16.97%
Cash/sh5.50 P/C16.36 EPS next 5Y12.10% ROE19.07% 52W Range62.35 - 94.50 Perf YTD16.33%
Dividend Est.0.11 (0.12%) P/FCF23.90 EPS past 5Y-2.54% ROI8.72% 52W High-4.81% Beta1.19
Dividend TTM0.12 (0.13%) Quick Ratio0.78 Sales past 5Y4.14% Gross Margin40.28% 52W Low44.27% ATR (14)1.86
Dividend Ex-DateApr 18, 2024 Current Ratio1.00 EPS Y/Y TTM-27.82% Oper. Margin12.89% RSI (14)53.89 Volatility1.81% 2.01%
Employees51000 Debt/Eq1.38 Sales Y/Y TTM6.60% Profit Margin7.08% Recom1.87 Target Price92.02
Option/ShortYes / Yes LT Debt/Eq1.23 EPS Q/Q-27.91% Payout3.97% Rel Volume0.24 Prev Close90.31
Sales Surprise2.21% EPS Surprise10.23% Sales Q/Q5.43% EarningsFeb 06 BMO Avg Volume3.58M Price89.95
SMA20-1.16% SMA506.54% SMA20019.27% Trades Volume69,011 Change-0.40%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated HSBC Securities Buy $100
Feb-12-24Upgrade UBS Sell → Neutral $66 → $88
Nov-30-23Initiated Jefferies Hold $80
Nov-27-23Downgrade UBS Neutral → Sell $86 → $66
Sep-19-23Initiated Citigroup Buy $82
Aug-25-23Initiated Argus Buy $80
Aug-16-23Initiated Wells Fargo Overweight $90
Jul-31-23Initiated BofA Securities Neutral $82
Jun-27-23Initiated Morgan Stanley Equal-Weight $76
May-16-23Initiated Oppenheimer Outperform $97
Mar-27-24 08:00AM
Mar-26-24 11:17AM
Mar-25-24 10:20AM
09:00AM
Mar-22-24 11:00AM
10:51AM Loading…
10:51AM
12:33AM
Mar-21-24 12:32PM
Mar-19-24 09:30AM
Mar-18-24 06:00PM
Mar-15-24 11:15AM
Mar-14-24 01:30PM
Mar-13-24 04:10PM
09:30AM
Mar-12-24 10:28PM
04:34PM Loading…
04:34PM
09:00AM
Mar-11-24 12:33PM
Mar-07-24 11:31AM
09:00AM
Mar-04-24 08:25AM
Mar-01-24 09:40AM
Feb-28-24 08:00AM
Feb-26-24 07:30AM
Feb-20-24 09:50AM
Feb-19-24 10:00AM
Feb-16-24 12:47AM
Feb-15-24 04:55PM
Feb-14-24 04:05PM
09:40AM
09:30AM Loading…
09:30AM
Feb-08-24 10:00AM
Feb-06-24 12:02PM
10:41AM
07:45AM
06:20AM
Feb-01-24 08:00AM
Jan-31-24 12:19PM
Jan-29-24 10:50AM
Jan-18-24 08:38AM
Jan-08-24 08:01AM
Dec-22-23 09:03AM
Dec-21-23 09:10AM
Dec-18-23 08:51AM
Dec-08-23 10:10AM
Dec-04-23 10:00AM
Nov-29-23 10:00AM
Nov-28-23 09:46AM
Nov-27-23 04:55PM
10:38AM
Nov-26-23 09:00AM
Nov-21-23 09:30AM
Nov-17-23 11:30AM
Nov-14-23 08:00AM
Nov-13-23 10:00AM
Nov-08-23 08:00AM
Nov-04-23 12:42PM
Nov-02-23 08:00AM
Oct-31-23 05:34PM
06:20AM
Oct-26-23 09:00AM
Oct-24-23 09:00AM
Oct-23-23 11:10AM
Oct-19-23 08:00AM
Oct-17-23 08:05AM
Oct-16-23 10:16AM
Oct-15-23 04:30PM
Oct-12-23 09:00AM
Oct-11-23 08:00AM
Oct-09-23 10:58AM
Oct-06-23 09:00AM
Oct-05-23 10:00AM
Sep-22-23 03:42PM
11:35AM
11:00AM
Sep-20-23 10:02AM
07:00AM
Sep-19-23 10:00AM
Sep-18-23 08:00AM
Sep-14-23 09:00AM
Sep-06-23 08:00AM
Aug-25-23 09:00AM
Aug-24-23 09:00AM
08:40AM
08:00AM
Aug-22-23 04:30PM
Aug-16-23 10:00AM
Aug-14-23 08:00AM
Aug-04-23 01:33PM
Jul-31-23 09:51AM
Jul-25-23 09:48PM
11:41AM
10:41AM
10:29AM
06:20AM
Jul-23-23 08:00AM
Jul-09-23 11:00AM
Jun-29-23 08:49AM
Jun-24-23 09:00AM
Jun-23-23 12:44PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Neill Kevin MichaelCEO, PDxJul 31 '23Option Exercise40.4013,275536,31037,300Aug 02 04:05 PM
O'Neill Kevin MichaelCEO, PDxJul 31 '23Sale77.3215,6091,206,94924,025Aug 02 04:05 PM
Rott RolandCEO, UltrasoundJun 08 '23Sale77.372,473191,33622,335Jun 12 04:06 PM